respiratori
infect
account
million
death
worldwid
inclus
tuberculosi
relat
death
push
figur
close
million
lower
respiratori
tract
infect
third
lead
caus
death
worldwid
prioriti
vaccin
develop
research
respiratori
immun
respons
therefor
central
campaign
decreas
global
burden
diseas
public
recognit
threat
respiratori
infect
recent
increas
due
public
surround
emerg
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
caus
atyp
pneumonia
high
mortal
anoth
signific
respiratori
pathogen
also
captur
media
interest
influenza
viru
use
surfac
express
protein
haemagglutinin
neuraminidas
penetr
host
cell
sinc
protein
express
surfac
viru
expos
immun
system
mutat
introduc
viral
genom
replic
rna
polymeras
result
antigen
distinct
influenza
strain
term
antigen
drift
therebi
avoid
immun
recognit
alarmingli
howev
swap
whole
gene
segment
two
differ
influenza
strain
infect
cell
term
antigen
shift
antigen
shift
thought
respons
influenza
pandem
includ
spanish
flu
kill
least
million
peopl
first
world
war
infect
approxim
half
world
popul
unusu
pandem
particularli
fatal
young
adult
although
sequenc
haemagglutinin
gene
viru
known
live
viru
avail
studi
make
basi
high
pathogen
far
elus
sourc
spanish
flu
thought
avian
reservoir
similar
clinic
outcom
observ
chicken
flu
outbreak
hong
kong
caus
avian
influenza
strain
six
infect
peopl
die
symptom
associ
infect
febril
influenzalik
ill
upper
lower
respiratori
tract
ill
multiorgan
failur
unlik
anim
model
use
examin
infecti
diseas
human
never
free
previou
concurr
infect
addit
complic
cofactor
includ
malign
cancer
autoimmun
condit
toxin
ingest
inhal
smoke
alcohol
drug
abus
trauma
exampl
surgeri
congenit
defect
precis
combin
event
requir
caus
mortal
often
overlook
focus
one
pathogen
one
beyond
infanc
respect
infect
inde
sequenc
infect
histori
alter
respons
subsequ
unrel
organ
simultan
infect
norm
rather
except
immun
mediat
elimin
one
pathogen
may
allow
anoth
escap
uncheck
lead
local
system
diseas
studi
perform
influenza
pandem
show
incid
associ
bacteri
pneumonia
rang
depend
popul
studi
streptococcu
pneumonia
haemophilu
influenza
staphylococcu
aureu
haemolt
streptococci
escherichia
coli
neisseria
meningitidi
aspergillu
fumigatu
branhamella
catarrhali
promin
describ
date
rais
chicken
egg
question
viral
infect
predispos
bacteri
super
infect
vice
versa
also
combin
infect
result
death
diseas
alter
reaction
one
pathogen
though
bacteri
proteas
may
assist
influenza
infect
cleav
heamagglutinin
precursor
form
allow
viral
attach
evid
suggest
influenza
viru
inadvert
assist
bacteri
replic
respiratori
tract
paper
issu
clinic
experiment
immunolog
seki
et
al
investig
interact
signific
respiratori
pathogen
pneumonia
p
aeruginosa
influenza
viru
fatal
occur
mice
infect
three
pathogen
two
combin
unlik
scenario
report
previous
mice
coinfect
pneumonia
influenza
viru
differ
like
attribut
dose
pathogen
use
mechan
influenza
viru
increas
occurr
secondari
bacteri
infect
numer
fig
epitheli
layer
cover
mucosa
provid
effect
first
line
barrier
prevent
pathogen
commens
entri
fig
respiratori
virus
commonli
replic
within
epithelium
may
caus
cell
death
exhaust
host
protein
synthesi
replic
viral
genom
direct
lysi
infect
cell
adher
staphylococci
visibl
lung
autopsi
specimen
pandem
area
viru
replic
caus
death
respiratori
epithelium
pneumococci
also
adher
vitro
cultur
tracheal
biopsi
coinfect
respiratori
tract
devoid
epithelium
due
previou
influenza
infect
vivo
cell
preincub
influenza
cytopath
viru
therefor
open
flood
gate
allow
access
submucos
layer
receptor
bacteria
may
bind
fig
infect
respiratori
epitheli
cell
alert
immun
system
presenc
invad
releas
inflammatori
cytokineschemokin
engag
recruit
cell
infect
cell
must
also
upregul
batteri
adhes
mhc
complement
bind
molecul
evolutionari
relationship
host
pathogen
allow
certain
bacteri
strain
use
upregul
molecul
bind
receptor
exampl
influenza
viru
upregul
platelet
activ
factor
receptor
pafr
certain
strain
pneumococci
express
phosphorylcholin
bind
inde
inhibit
pafr
delay
mortal
influenza
pneumococcu
dual
infect
mice
abil
virus
enhanc
bacteri
adhes
restrict
influenza
sinc
adenoviru
infect
lung
epitheli
cell
line
also
increas
pneumococcu
adher
complement
protein
act
substrat
adhes
pneumonia
polymer
receptor
respons
transloc
dimer
iga
pentamer
igm
across
mucos
epithelium
inadvert
assist
movement
pneumococci
across
nasopharyg
epitheli
cell
action
influenza
neuraminidas
may
directli
expos
critic
structur
requir
secondari
bacteri
adher
neuraminidas
releas
newli
synthes
viru
cleav
sialic
acid
host
glycoprotein
bud
prevent
viral
aggreg
inhibit
viru
bind
respiratori
tract
mucin
consequ
pathogen
commens
bacteri
vista
suddenli
chang
inform
regard
abil
virus
modul
bacteri
attach
adhes
molecul
howev
limit
incomplet
knowledg
precis
receptor
involv
addit
exposur
potenti
receptor
secondari
pathogen
may
escap
elimin
immun
system
otherwis
occupi
inappropri
make
fig
mani
interconnect
pathway
exist
either
prevent
exagger
immun
respons
elicit
correct
immunolog
environ
type
cytokin
produc
cell
inhibit
develop
cell
ensur
domin
respons
infect
appropri
regulatori
cell
produc
immun
suppress
cytokin
limit
extent
immun
prevent
bystand
tissu
damag
autoimmun
imbal
signal
requir
prevent
bacteri
infect
may
occur
indirectli
influenza
viru
infect
addit
induc
environment
alter
virus
evolv
numer
strategi
inhibit
specif
immun
compart
macrophag
promin
antigen
present
cell
airway
recruit
activ
inhibit
influenza
infect
neutrophil
apoptosi
also
featur
influenza
viru
infect
sinc
immun
compart
obvious
critic
clearanc
bacteria
dysfunct
favour
bacteri
prolifer
fig
outcom
multipl
infect
may
depend
time
initi
infect
pneumococcu
dampen
mortal
subsequ
influenza
viru
challeng
though
mechan
respons
known
result
gener
reminisc
studi
show
previou
influenza
viru
infect
improv
immunopatholog
subsequ
respiratori
syncyti
viru
infect
lung
latter
studi
tnf
product
second
infect
reduc
may
therefor
explain
reduc
cachexia
weight
loss
howev
pneumococc
infect
day
influenza
viru
infect
sever
exacerb
diseas
otherwis
observ
either
infect
alon
lead
extens
pulmonari
consolid
enhanc
bacteraemia
death
whatev
mechan
pathogen
involv
outcom
usual
occlus
respiratori
airway
excess
inflammatori
cell
fig
seki
et
al
reduct
inflamm
deplet
cell
subset
inhibit
inflammatori
cytokin
blockad
signal
requir
cell
activ
though
benefici
yet
test
experiment
system
contain
multipl
pathogen
rare
infect
pathogen
absenc
underli
infect
complic
challeng
futur
therefor
take
consider
design
test
futur
immun
therapeut
